Based on the significant unmet need in Alzheimers disease as well as a number of indicative data points, we felt we had a responsibility to explore semaglutides potential, despite a low likelihood of success, Martin Holst Lange, chief scientific officer at Novo Nordisk said in a press release
How much weight can you lose in a month with GLP-1 injections
However, the chemical composition of GSH does not allow it to be taken orally for central nervous system diseases because little to none crosses the blood-brain barrier
For more information about how these drugs compare, see this article
Lymphatic drainage and detoxification treatments
Since mitochondria cannot synthesize the negatively charged GSH, SLC25A39 is crucial for maintaining GSH homeostasis within the mitochondria [24]